443 related articles for article (PubMed ID: 27926921)
21. DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection.
Gonçalves de Assis NR; Batistoni de Morais S; Figueiredo BC; Ricci ND; de Almeida LA; da Silva Pinheiro C; Martins Vde P; Oliveira SC
PLoS One; 2015; 10(5):e0125075. PubMed ID: 25942636
[TBL] [Abstract][Full Text] [Related]
22. A combined Haemophilus influenzae type B Neisseria meningitidis serogroup C tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when coadministered with diphtheria, tetanus, acellular pertussis hepatitis B-inactivated poliovirus at 3, 5 and 11 months of age: results of an open, randomized, controlled study.
Vesikari T; Forstén A; Desole MG; Ferrera G; Caubet M; Mesaros N; Boutriau D
Pediatr Infect Dis J; 2013 May; 32(5):521-9. PubMed ID: 23190785
[TBL] [Abstract][Full Text] [Related]
23. Schistosoma mansoni Infection of Mice, Rats and Humans Elicits a Strong Antibody Response to a Limited Number of Reduction-Sensitive Epitopes on Five Major Tegumental Membrane Proteins.
Krautz-Peterson G; Debatis M; Tremblay JM; Oliveira SC; Da'dara AA; Skelly PJ; Shoemaker CB
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005306. PubMed ID: 28095417
[TBL] [Abstract][Full Text] [Related]
24. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine.
Tejedor JC; Moro M; Ruiz-Contreras J; Castro J; Gómez-Campderá JA; Navarro ML; Merino JM; Martín-Ancel A; Roca J; García-del-Río M; Jurado A; Díez-Delgado FJ; Omeñaca F; García-Sicilia J; Boceta R; García-Corbeira P; Jacquet JM; Collard A; Schuerman L;
Pediatr Infect Dis J; 2006 Aug; 25(8):713-20. PubMed ID: 16874171
[TBL] [Abstract][Full Text] [Related]
25. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
Laws HJ; Calaminus G; Göbel U
Cancer; 2005 Apr; 103(8):1759; author reply 1760. PubMed ID: 15717299
[No Abstract] [Full Text] [Related]
26. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
Fioredda F; Giacchino M; Castagnola E
Cancer; 2005 Apr; 103(8):1758-9; author reply 1760. PubMed ID: 15717298
[No Abstract] [Full Text] [Related]
27. Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation.
Vance E; George S; Guinan EC; Wheeler C; Antin JH; Ambrosino DM; Molrine DC
Bone Marrow Transplant; 1998 Oct; 22(8):735-41. PubMed ID: 9827969
[TBL] [Abstract][Full Text] [Related]
28. Immunological response to diphtheria/tetanus vaccine in Schistosomiasis mansoni patients.
el Ghorab NM; Bassily S; Fouad S; el-Masry NA; Boctor F; Kamal KA
J Egypt Soc Parasitol; 1992 Dec; 22(3):747-65. PubMed ID: 1431294
[TBL] [Abstract][Full Text] [Related]
29. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
[TBL] [Abstract][Full Text] [Related]
30. Influence of preimmunization with tetanus toxoid on immune responses to tetanus toxin fragment C-guest antigen fusions in a Salmonella vaccine carrier.
Chabalgoity JA; Villareal-Ramos B; Khan CM; Chatfield SN; de Hormaeche RD; Hormaeche CE
Infect Immun; 1995 Jul; 63(7):2564-9. PubMed ID: 7790070
[TBL] [Abstract][Full Text] [Related]
31. Impact of Mothers' Schistosomiasis Status During Gestation on Children's IgG Antibody Responses to Routine Vaccines 2 Years Later and Anti-Schistosome and Anti-Malarial Responses by Neonates in Western Kenya.
Ondigo BN; Muok EMO; Oguso JK; Njenga SM; Kanyi HM; Ndombi EM; Priest JW; Kittur N; Secor WE; Karanja DMS; Colley DG
Front Immunol; 2018; 9():1402. PubMed ID: 29967622
[TBL] [Abstract][Full Text] [Related]
32. Role of host antibody in the chemotherapeutic action of praziquantel against Schistosoma mansoni: identification of target antigens.
Brindley PJ; Strand M; Norden AP; Sher A
Mol Biochem Parasitol; 1989 May; 34(2):99-108. PubMed ID: 2496307
[TBL] [Abstract][Full Text] [Related]
33. Immunogenicity, antibody responses and vaccine efficacy of recombinant annexin B30 against Schistosoma mansoni.
Leow CY; Willis C; Chuah C; Leow CH; Jones M
Parasite Immunol; 2020 Mar; 42(3):e12693. PubMed ID: 31880816
[TBL] [Abstract][Full Text] [Related]
34. In vitro cellular and humoral responses to Schistosoma mansoni vaccine candidate antigens.
Al-Sherbiny M; Osman A; Barakat R; El Morshedy H; Bergquist R; Olds R
Acta Trop; 2003 Oct; 88(2):117-30. PubMed ID: 14516923
[TBL] [Abstract][Full Text] [Related]
35. Associations between specific antibody responses and resistance to reinfection in a Senegalese population recently exposed to Schistosoma mansoni.
Vereecken K; Naus CW; Polman K; Scott JT; Diop M; Gryseels B; Kestens L
Trop Med Int Health; 2007 Mar; 12(3):431-44. PubMed ID: 17313515
[TBL] [Abstract][Full Text] [Related]
36. Randomized trial to assess immunogenicity and safety of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in infants.
Marchant CD; Miller JM; Marshall GS; Blatter M; Aris E; Friedland LR; Boutriau D;
Pediatr Infect Dis J; 2010 Jan; 29(1):48-52. PubMed ID: 20035207
[TBL] [Abstract][Full Text] [Related]
37. Immunogenicity, safety, and antibody persistence at 3, 5, and 10 years postvaccination in adolescents randomized to booster immunization with a combined tetanus, diphtheria, 5-component acellular pertussis, and inactivated poliomyelitis vaccine administered with a hepatitis B virus vaccine concurrently or 1 month apart.
Embree J; Law B; Voloshen T; Tomovici A
Clin Vaccine Immunol; 2015 Mar; 22(3):282-90. PubMed ID: 25540274
[TBL] [Abstract][Full Text] [Related]
38. Antibody responses to tetanus toxoid and Haemophilus influenzae type b conjugate vaccines following autologous peripheral blood stem cell transplantation (PBSCT).
Chan CY; Molrine DC; Antin JH; Wheeler C; Guinan EC; Weinstein HJ; Phillips NR; McGarigle C; Harvey S; Schnipper C; Ambrosino DM
Bone Marrow Transplant; 1997 Jul; 20(1):33-8. PubMed ID: 9232253
[TBL] [Abstract][Full Text] [Related]
39. Primary and booster immunization with a diphtheria, tetanus, acellular pertussis, hepatitis B (DTPa-HBV) and Haemophilus influenzae type b (Hib) vaccine administered separately or together is safe and immunogenic.
Marshall H; McIntyre P; Roberton D; Dinan L; Hardt K
Int J Infect Dis; 2010 Jan; 14(1):e41-9. PubMed ID: 19467896
[TBL] [Abstract][Full Text] [Related]
40. Improved immunogenicity of tetanus toxoid by Brucella abortus S19 LPS adjuvant.
Mohammadi M; Kianmehr Z; Kaboudanian Ardestani S; Gharegozlou B
Iran J Immunol; 2014 Sep; 11(3):189-99. PubMed ID: 25266004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
